Ranquilon or Afobazole for anxiety and adjustment difficulties
About this title
Read the official source — NCT06843044Researchers are comparing Ranquilon and Afobazole to find out how the approaches affect anxiety symptoms in people with an anxiety condition.
Understand this study
What is this study about?
Researchers are comparing Ranquilon and Afobazole to find out how the approaches affect anxiety symptoms in people with an anxiety condition.
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- Engel's and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 250
- Sponsor
- Valenta Pharm JSC
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Russia
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06843044
- Official title
Show the full official title
An Open-label, Comparative, Randomized, Multicenter Phase IV Clinical Study to Evaluate the Clinical Efficacy and Safety of the Drug Ranquilon, Tablets, 1 mg, in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders
Recruitment & locations
Engel's, Russia · Moscow, Russia · Saint Petersburg, Russia
2 more locations
- Saratov, Russia
- Russia
Registry details
Anxiety; Neurasthenia; Adjustment Disorders
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing Ranquilon and Afobazole to find out how the approaches affect anxiety symptoms in people with an anxiety condition.
Who is behind this study?
The study sponsor is Valenta Pharm JSC.
Does this study involve medication?
Yes. The study involves medication, including Ranquilon and Afobazole.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
